4:31 PM
 | 
Oct 11, 2018
 |  BC Week In Review  |  Company News  |  Deals

Philadelphia groups partner to target Tregs for lung cancer

AUM LifeTech Inc. (Philadelphia, Pa.), Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania partnered to develop an RNA silencing immunotherapy to treat lung cancer.

The therapeutic, which comprises fluoroarabinonucleic acid (FANA) antisense oligonucleotides (ASOs),...

Read the full 187 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >